Evaluation of the effectiveness of propolis dietary supplement on metabolic syndrome

Phase 3

• Conditions: Metabolic syndrome.; Metabolic syndrome; E88.81

• Registration Number: IRCT20121216011763N49
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 August 2022

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients with metabolic syndrome according to (NCEP-ATP III)
Willingness to participate in the study
Adults 20-60 years old
Having the ability to read and write

Exclusion Criteria

Pregnancy and lactation
Having the following disease: Malignancies or cancer, type I diabetes, nephrotic syndrome, kidney and lung disease, biliary disease, and HIV
Sensitivity to bee products
Adherence a weight loss diet or physical activity program
Tobacco and alcohol consumption
Insulin injection
Change in the type and dosage of medication from 3 months before entering the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Homeostasis model assessment insulin resistance (HOMA-IR). Timepoint: At the beginning of the study and 12 weeks after supplementation. Method of measurement: ( fasting plasma glucose × fasting Insulin)/22.5.